Contact Us
Lifecore logo in two versions of blue

Technology Transfer Series

Methods Matter: Keeping In-Transit Methods Intact

A person handing a tube to another person

Analytical method transfer is the formal proof that a receiving laboratory can run a method reliably, reproducibly, and in alignment with the originating site. Method maturity directly determines how quickly a CDMO can scale, validate, and manufacture a GMP product. Analytical readiness is not optional; it dictates whether timelines hold, change controls multiply, or redevelopment emerges mid-program. The earlier data, reports, and historical context are shared, the more smoothly the transfer proceeds. Here are seven important considerations for ensuring smooth method transfer.

1. CQAs First, or Everything Slows

Analytical methods define how a product is measured, controlled, and released. They establish how CQAs are assessed, how impurities are tracked, and how degradation and stability are interpreted. When CQAs are unclear or still evolving, methods tend to evolve alongside them, stretching timelines. While CDMOs bring execution expertise, sponsors remain the authority on what truly matters about their product.

2. Specs Don’t Always Tell the Full Story

A frequent pitfall is the assumption that a specification implies a standard method. In practice, many specifications mask non-compendial or heavily modified methods that emerge only after transfer begins. When the complete method surfaces later, project scope, cost, and timing may need to be reevaluated. Reviewing raw data—not just summary reports—often reveals issues that paper assessment alone fails to expose.

3. What Transfer-Ready Actually Means

Transfer-ready methods are not perfect; they are clear, stable, and supported by sufficient historical data. Sponsors should be prepared to provide SOPs, development reports, validation or qualification documentation, representative chromatograms, forced degradation data, and records of trends or deviations. Together, these materials allow assessment of method maturity and the appropriate transfer strategy.

Male and female scientist in a lab, talking discussing data on a laptop.

4. Match Method Maturity to Clinical Reality

Method rigor must align with clinical phase. Early-phase methods need sound science, while safety-critical tests always require full validation. By Phase 2, non-compendial methods typically need protocol-based qualification. By Phase 3, full validation or verification becomes mandatory. Underestimating the effort to elevate methods between phases often leads to delays or revalidation.

5. Picking the Right Transfer Path

Simple comparative studies work well for robust or mature methods. Complex methods tied to key CQAs may require supplemental validation elements. Co-validation can be effective but demands tight coordination. The most resource-intensive option—full revalidation—usually results from limited support or foundational method flaws uncovered during feasibility.

6. Analytics Drive Process, Not the Other Way Around

Analytical readiness directly shapes process transfer and scale-up. CQAs inform mixing strategies, hold times, filtration, and filling decisions. Methods such as assay, impurities, and viscosity provide critical feedback during engineering runs. If analytical precision is inadequate, process understanding inevitably suffers.

7. Control Works Only When Measurement Works

Process capability depends on method variability relative to specifications. Narrow limits combined with noisy methods increase the risk of ambiguous results. Early evaluation of variability helps determine appropriate testing strategies and whether a method requires refinement. Strong control strategies link CQAs, process parameters, and analytical performance into a coherent whole.

Readiness Creates Momentum

The real value of an experienced CDMO in method transfer lies in anticipation; recognizing where methods commonly fail and helping address gaps before they become delays. When gaps are identified early, programs avoid costly surprises later. In a milestone-driven environment, analytical rigor is what keeps development predictable and execution confident.

Lifecore’s Tech Transfer Expertise

With a range of successful transfers from early-stage to commercial supply, the Lifecore team understands what it takes to transfer a project smoothly. We ensure that everyone is aligned on the process, the product, and the long-term goals. Our multi-disciplined team structure means project leads manage day-to-day work, identifying risks and escalating when needed; managers provide oversight and help to move decisions forward; and executives remain on hand to quickly provide higher-level guidance if required.

Plus, with deep experience in handling complex products, our technical experts are effective at addressing process development and manufacturing challenges throughout the transfer.

This article is part of Lifecore’s Technology Transfer Series. For the full picture on getting tech transfer right the first time, visit our Insider’s Guide to Right-First-Time Tech Transfer.

If you need help with tech transfer, contact us to explore how we could work together.